M. Deberne

446 total citations · 1 hit paper
14 papers, 162 citations indexed

About

M. Deberne is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Deberne has authored 14 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Deberne's work include Colorectal and Anal Carcinomas (5 papers), Colorectal Cancer Surgical Treatments (4 papers) and Advanced Radiotherapy Techniques (3 papers). M. Deberne is often cited by papers focused on Colorectal and Anal Carcinomas (5 papers), Colorectal Cancer Surgical Treatments (4 papers) and Advanced Radiotherapy Techniques (3 papers). M. Deberne collaborates with scholars based in France, Switzerland and United Kingdom. M. Deberne's co-authors include Laurent Mineur, Nicolas Magné, N. Barbet, A.S. Dhadda, Arthur Sun Myint, Thomas Zilli, I. Martel, Renaud Schiappa, Jean‐Pierre Gérard and Bertrand Billemont and has published in prestigious journals such as Journal of Clinical Oncology, BMC Cancer and Acta Oncologica.

In The Last Decade

M. Deberne

13 papers receiving 158 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

2023 77 citations Jean‐Pierre Gérard, N. Barbet et al. The Lancet. Gastroenterology & hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Deberne France	7	114	96	45	25	21	14	162
M.C. Dobelbower United States	6	92 0.8×	52 0.5×	81 1.8×	28 1.1×	50 2.4×	12	182
Silvia Foti Italy	4	81 0.7×	48 0.5×	52 1.2×	13 0.5×	32 1.5×	25	135
Markus Diefenhardt Germany	8	137 1.2×	78 0.8×	36 0.8×	15 0.6×	47 2.2×	28	195
Elisa Palazzari Italy	8	92 0.8×	57 0.6×	31 0.7×	18 0.7×	13 0.6×	28	173
S. Vieillot France	7	85 0.7×	104 1.1×	117 2.6×	57 2.3×	23 1.1×	19	191
Lorraine Walsh Canada	5	36 0.3×	59 0.6×	48 1.1×	45 1.8×	27 1.3×	7	146
Charlotte A.H. Lange Netherlands	8	74 0.6×	86 0.9×	57 1.3×	25 1.0×	61 2.9×	15	209
Dashan Ai China	9	132 1.2×	202 2.1×	199 4.4×	9 0.4×	27 1.3×	21	294
Aurora Rodríguez Spain	8	42 0.4×	45 0.5×	65 1.4×	27 1.1×	46 2.2×	21	161
Israël Fortin Canada	7	32 0.3×	80 0.8×	22 0.5×	26 1.0×	18 0.9×	11	228

Countries citing papers authored by M. Deberne

Since Specialization

Citations

This map shows the geographic impact of M. Deberne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Deberne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Deberne more than expected).

Fields of papers citing papers by M. Deberne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Deberne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Deberne. The network helps show where M. Deberne may publish in the future.

Co-authorship network of co-authors of M. Deberne

This figure shows the co-authorship network connecting the top 25 collaborators of M. Deberne. A scholar is included among the top collaborators of M. Deberne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Deberne. M. Deberne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gérard, Jean‐Pierre, N. Barbet, Renaud Schiappa, et al.. (2023). Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial. The Lancet. Gastroenterology & hepatology. 8(4). 356–367. 77 indexed citations breakdown →

Myint, Arthur Sun, Christopher Rao, N. Barbet, et al.. (2023). The safety and efficacy of total mesorectal excision (TME) surgery following dose‐escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750). Colorectal Disease. 25(11). 2160–2169. 3 indexed citations

Gérard, Jean-Pierre, N. Barbet, Nicolas Magné, et al.. (2022). Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: The 3-year results of OPERA randomized trial (NCT02505750).. Journal of Clinical Oncology. 40(16_suppl). 3512–3512. 15 indexed citations

Beddok, Arnaud, L. Feuvret, G. Noël, et al.. (2019). Complément de dose de protons pour les cancers du nasopharynx localement évolués : une expérience de l’institut Curie. Cancer/Radiothérapie. 23(4). 304–311. 3 indexed citations

Beddok, Arnaud, L. Feuvret, G. Noël, et al.. (2019). Efficacy and toxicity of proton with photon radiation for locally advanced nasopharyngeal carcinoma. Acta Oncologica. 58(4). 472–474. 14 indexed citations

d’Hombres, A., et al.. (2017). Formation à l’hypnose et son impact pour le patient et les professionnels dans le département de radiothérapie des Hospices civils de Lyon. Cancer/Radiothérapie. 21(6-7). 718–718. 1 indexed citations

Deberne, M., et al.. (2016). Multimodal management of primary adenocarcinoma of the female urethra: About four cases. Cancer/Radiothérapie. 20(3). 169–175. 5 indexed citations

Deberne, M., Stanislas Ropert, Bertrand Billemont, et al.. (2014). Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?. BMC Cancer. 14(1). 416–416. 17 indexed citations

Deberne, M., Antonin Lévy, Michele Mondini, et al.. (2013). The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines’ in-vitro and in-vivo xenografts. Anti-Cancer Drugs. 24(6). 599–608. 11 indexed citations

10.

Châtellier, Gilles, Anne Berger, Jean‐François Emile, et al.. (2013). Tolérance et efficacité de la radiothérapie préopératoire chez les patients âgés atteints d’un cancer du rectum. Cancer/Radiothérapie. 17(3). 202–207. 6 indexed citations

11.

Chargari, Cyrus, et al.. (2011). Ciblage pharmacologique de Mdm2 : bases biologiques et perspectives de radiosensibilisation. Cancer/Radiothérapie. 15(4). 316–322. 1 indexed citations

12.

Ali, David, et al.. (2011). Recommandations de délinéation des organes à risque en radiothérapie ORL. Cancer/Radiothérapie. 15(6-7). 582–582. 1 indexed citations

13.

Rodrigues, Manuel, et al.. (2010). Le cancer en Afrique, un nouveau défi sanitaire. Exemples du Mali et de l'association OncoMali. Bulletin du Cancer. 97(8). 965–968. 8 indexed citations

14.

Deberne, M., F. Huguet, Romuald Le Scodan, Pascal Hammel, & Thierry André. (2007). [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].. PubMed. 94(1). 72–80.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact